MYXREDLIN
MYXREDLIN
Approved
DIN Number
02529602
Drug Class
Human
Market Date
Jul 28, 2023
Company
HC
baxter corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02529602
AIG Number0152199004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
A10AB01 INSULIN (HUMAN)
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification68:20.08.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
INSULIN (HUMAN)Active
Strength: 1 UNIT / ML
Monograph: INSULIN (HUMAN)